Background: Fibrous cephalic plaques (FCPs) stereotypically develop on the forehead of patients with tuberous sclerosis complex (TSC). They constitute a major feature for TSC diagnosis and may present before other TSC-related cutaneous hamartomas.
T uberous sclerosis complex (TSC) has wide phenotypic variability characterized by the formation of benign tumors in multiple organs.
1,2 TSC results from an inactivating mutation in either tuberous sclerosis 1 gene (TSC1) or tuberous sclerosis 2 gene (TSC2), leading to aberrant activation of the mechanistic target of rapamycin (mTOR) signaling cascade in tumors. 3 The 2 most commonly affected organs are the brain and skin. Brain involvement is usually discovered when a child presents with seizures. 1 Nearly all patients with TSC develop dermatologic lesions such as facial angiofibromas, hypomelanotic macules, shagreen patches, ungual fibromas, and fibrous cephalic plaques (FCPs). 4 These lesions are included in the major diagnostic criteria from the 2012 International Tuberous Sclerosis Complex Consensus Conference. 5 The use of clinical diagnostic criteria and genetic testing promotes timely and accurate diagnosis. However, diagnostic delay is not uncommon, with TSC diagnosed in some individuals decades after the appearance of characteristic skin lesions. 6 In nearly 12% of patients with TSC, the disease is not diagnosed until adulthood, usually after an affected child receives the diagnosis. 7 One contributing factor for delayed diagnosis may be failure to consider TSC in those lacking seizures; up to 15% of patients do not report a history of seizures. 8 Another factor may be poor recognition of characteristic skin lesions, including FCPs.
FCPs may present at birth and commonly become noticeable in early childhood. 9 Seminal reports documented these plaques on the scalp or face of patients with TSC and described histopathologic similarities to angiofibromas. 10, 11 Concepts and terminologies have varied, with some authors grouping lesions on the face or scalp, some discussing them separately as forehead plaques and scalp fibromas, and others using the term forehead plaque to include all lesions on the face and scalp. This makes it challenging to assess the literature with regard to frequencies of these lesions, which are reported as 19% to 36% for forehead plaques, 9, 12 13% to 30% for scalp fibromas, 13,14 and 46% overall. 15 A potential source of variability is that forehead plaques are more common in patients with mutations in TSC2 than in those with mutations in TSC1 (40% vs 10%). 12 It is also likely that small lesions, especially if covered by hair on the scalp, are easily missed.
Our goal was to describe the clinical and histopathologic characteristics of FCPs in TSC. Herein we report the full scope and less classic presentations of FCPs to improve recognition of this diagnostic feature.
PATIENTS AND METHODS
A total of 113 adult patients with TSC were examined at the National Institutes of Health (NIH) in Bethesda, Maryland, from 1998 to 2016. Each provided written informed consent per protocols 00-H-0051, 95-H-0186, and/or 82-H-0032, which were approved by the National Heart, Lung, and Blood Institute Institutional Review Board. All patients met the revised diagnostic criteria of the 2012 International Tuberous Sclerosis Complex Consensus.
The cohort was enriched for those with pulmonary lymphangioleiomyomatosis and therefore consisted mostly of women. 16 Patients were evaluated for the presence or absence of FCPs and queried regarding the age of onset of their lesion(s). Paired samples of FCP and normal-appearing skin were obtained from 11 patients and sections stained with routine hematoxylin and eosin.
Pictures were taken. Lesions were classified according to size on the basis of length of the major axis: 1 to less than 5 cm and 5 cm or larger (large FCPs). These categories were arbitrarily selected to provide information on size distribution in this population. Anatomic location was mapped onto a 3-dimensional mannequin head and subsequently outlined on a representative head by using Adobe Illustrator. Similar-appearing lesions less than 1 cm in diameter and clinically distinct from classic angiofibromas were also mapped. Lesions were classified as left, right, or midline. Statistical analysis of lesion lateralization was conducted by using the Wilcoxon signed rank test.
RESULTS

Fibrous cephalic plaques
Frequency. The 113 adult patients with TSC comprised 108 women and 5 men ranging in age from 30 to 72 years (median age, 46 years) ( Table I) . A total of 41 patients (36%), 1 of whom was male, had a FCP. A total of 62 lesions were categorized by size into 36 ''typical'' FCPs (1 to \5 cm), 8 large FCPs ($5 cm), 16 FCPs of unknown size that were excised, and 2 FCPs whose size could not be accurately determined from photos or medical records (Table II) brown plaques (Fig 1, A) . Patients with more darkly pigmented skin tended to have much darker lesions relative to surrounding skin than did patients with lightly pigmented skin (Fig 1, B) . FCPs on the scalp were associated with decreased hair density in the location of the lesion (Fig 1, C ) . A total of 20 patients (49%) reported onset of FCP at birth or during the first year of life (Table I ). Many patients were unable to recall an age of onset, often because the lesions were unnoticed and asymptomatic. In all, 14 patients had excisions of 16 lesions, primarily for cosmetic reasons and rarely for bleeding or pain in the scalp. Lesions did not recur except in 1 patient who reported thickening and pain near the scar. TSC diagnosis was frequently delayed even in those having their lesions excised. The median delay in years from onset of FCP to TSC diagnosis was 16 years (range, À12 to 52; n = 28).
Location. The distribution of lesions was 24 (39%) on the forehead, 17 (27%) face (the nonforehead part), 2 (3%) neck, and 19 (31%) scalp. The outlines of these lesions are shown in Fig 2, excluding the 18 that could not be accurately mapped because of excision (7 on the forehead, 6 on the nonforehead part of the face, and 3 on the scalp) or inadequate documentation (1 on the forehead and 1 on the scalp). FCPs were more common on the left side, with 38 left-sided lesions (67%) and 19 right-sided lesions (33%), (which was significantly different from the 50% expected [P = .024], excluding 3 midline FCPs previously excised and 1 lesion with unknown laterality).
Histopathology. Of the 11 FCPs subjected to biopsy and histopathologic analysis, all had thickened, disorganized bundles of reticular collagen in the dermis with decreased elastic fibers compared with unaffected skin (Fig 3, A) . Many lesions exhibited increased dilated vessels as observed in angiofibromas (Fig 3, B) . Others showed involvement of hair follicles ranging from distorted hair follicles with extensive perifollicular fibroplasia to bundles of collagen surrounding cords of abnormal epithelium emanating from the infundibular portions of the hair follicles, similar to fibrofolliculomas (Fig 3, C ) . In addition, some samples exhibited fibrosis around eccrine glands.
Lesions smaller than 1 cm
In all, 14 patients (12%) had lesions similar to FCPs that were less than 1 cm in diameter (Fig 1, D) . Of these 14 patients, 5 did not have an accompanying FCP. There were a total of 23 lesions smaller than 
TSC, Tuberous sclerosis complex. tuberous sclerosis complex 1 cm, and the median number of lesions per patient was 1 (range, 1-5). Five patients (36%) had multiple lesions whereas 9 patients (64%) had solitary lesions. These lesions were skin-colored, pink, red, or brown papules. The majority of lesions less than 1 cm in diameter had an unknown age of onset. They were outside the typical locations for angiofibromas, often on the scalp or lateral face, and they did not arise from a confluence of angiofibromas. Of the 23 smaller lesions, 11 were located on the scalp (48%), 7 on the forehead (30%), and 5 on the face (22%) (Fig 2) . There were 13 left-sided lesions (57%), 9 right-sided lesions (39%), and 1 previously excised midline lesion (4%); a trend toward lesions on the left was not statistically significant (P = .54). Of the lesions smaller than 1 cm, 8 were histopathologically analyzed and showed features similar to those of FCPs, including thickened dermal collagen bundles and decreased elastic fibers. Some of the lesions additionally showed vascular changes similar to angiofibromas, as well as perifollicular fibroplasia.
DISCUSSION
Fibrous cephalic plaques were present in 36% of our cohort with TSC, which is within the range of 19% to 46% reported in previous studies. 9, 12, 15 Onset was commonly in infancy or early childhood. Lesions were significant enough to be excised in 34% of cases. Despite this, TSC diagnosis was often delayed until the late teens or adulthood, highlighting the need for improved recognition of this cutaneous manifestation of TSC. The stereotypic location for FCPs is the forehead, but only two-fifths were located on the forehead in our study. They occurred just as commonly on the nonforehead portions of the face and scalp, and more rarely on the neck. Most FCPs occurred as a solitary plaque, generally measuring 1 to 5 cm along the longest axis. In our experience, FCPs have a characteristic appearance, particularly when large, with few lesions displaying similar features. The differential diagnosis may include melanocytic nevi, keloids, cutaneous lymphomas, neurocristic cutaneous hamartomas, and granuloma faciale. These entities can be excluded on the basis of history and appearance, or by biopsy if required. The differential diagnosis may also include the folliculocystic and collagen hamartoma associated with TSC; 2 patients with TSC have been described with folliculocystic and collagen hamartomas on the scalp. In contrast to FCPs, these hamartomas show comedo-like openings that may drain a purulent material, and they may also occur on the trunk. 17, 18 The presence of a FCP or multiple facial angiofibromas is a major feature for diagnosis of TSC; 1 additional major feature is sufficient for a clinical diagnosis. 5 A child with a FCP has possible TSC and should have a thorough diagnostic evaluation regardless of documented seizures. 19 FCPs may present before other manifestations of TSC, as an isolated skin finding or with hypomelanotic macules, which is the most common cutaneous manifestation of TSC in infancy. 9, 20 FCPs can be disfiguring, leading to stigmatization and low selfesteem. In our study, 14 patients had lesions excised primarily for cosmetic reasons. Alternatives to surgical excision include vascular laser therapy for erythematous lesions or ablation with a CO 2 laser. 4, 21 A combination of pinpoint electrosurgery, pulsed dye laser, and ablative fractional resurfacing was shown to flatten and soften an FCP in 1 patient. 22 The potential for treating these lesions using an mTOR inhibitor was suggested by studies demonstrating that fibroblast-like cells grown from FCPs show activation of mTOR signaling because of biallelic mutations in TSC2 and treatment responses observed in xenograft and conditional knockout models. [23] [24] [25] Recently, topical 1% sirolimus cream was shown to improve the appearance of FCPs in 9 of 16 patients after 3 to 9 months of treatment. 26 Interestingly, FCPs were more common on the left side in our cohort. It appears that large shagreen patches in patients with TSC also predominate on the left side. 27 This may be spurious, but a potential biologic explanation can be postulated on the basis of the role of the primary cilium in lateralization. Loss of Tsc1 or Tsc2 leads to aberrations in the length of the primary cilium in mouse embryonic fibroblasts, 28, 29 and morpholino knockdown of tsc1a in zebrafish causes ciliary dysfunction and left-right asymmetry defects. 30 The manner in which abnormalities in the primary cilium might affect embryonic development and subsequent tumor localization is unknown. Further studies are warranted to confirm possible lateralization.
Histopathologic examination of FCPs revealed thickened bundles of reticular collagen with decreased or absent elastic fibers. In addition to these features, with similarities to the shagreen patch of TSC, lesions frequently showed focal areas that were histopathologically similar to angiofibroma, perifollicular fibroma, fibrofolliculoma, or a combination thereof. Angiofibromatous changes have been documented previously in forehead plaques 9 and a scalp fibroma. 31 Multiple fibrofolliculomas are classic for Birt-Hogg-Dub e (BHD) syndrome, but a facial fibrofolliculoma was previously reported in a patient with TSC. 32 Our observations indicating variable stromal and epithelial findings in FCPs, with a histopathologic spectrum varying from angiofibroma to fibrofolliculoma, support the proposition that cutaneous hamartomas in TSC and BHD syndrome share a common histogenesis. 33 In addition to FCPs, 12% of our cohort presented with lesions that were similar in clinical and histopathologic appearance to FCPs but measured less than 1 cm in diameter. These lesions do not fulfill the diagnostic criteria. The clinical diagnostic certainty is less for these small lesions than for large FCPs. In the absence of other TSC-related skin findings, confirmation with a skin biopsy is necessary. Patients with histopathologically confirmed, small FCP-like lesions should be questioned for a personal or family history suggestive of TSC, closely examined for additional mucocutaneous features of TSC, and considered for complete diagnostic evaluation. This presentation and work-up are analogous to those for small collagenomas less than 1 cm in diameter that do not meet criteria for shagreen patch. 27 Limitations of this study include the retrospective design, use of patient-reported onset of FCPs, and small sample size for histopathologic analysis. Ages of onset were by patient or parent recollection, and a prospective study is needed to define when these lesions appear. Our cohort mainly comprised adult women because of enrichment for those with pulmonary lymphangioleiomyomatosis, which occurs almost exclusively in women. It is possible that our results are not generalizable to men with TSC. However, 1 study found no significant difference between frequency of fibrous forehead plaques in men and in women. 34 We did not observe the evolution of these lesions from early childhood, although FCPs in adulthood remained stable over time. FCPs in children have been observed to grow slowly and become raised. 9 
CONCLUSIONS
Only about two-fifths of FCPs present on the classic location of the forehead, with the remainder split between other locations on the face, neck, or scalp. In addition to thickened collagen and decreased elastic fibers, FCPs frequently show stromal and epithelial changes that fall on a spectrum between angiofibromas of TSC and fibrofolliculomas of BHD syndrome. Better recognition of these lesions by clinicians may help to ensure prompt diagnosis, early treatment initiation, and appropriate referral for follow-up of other TSCrelated sequelae.
